11.40
+0.30
+(2.70%)
As of 8:16:34 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-140,617.00
-19,431.00
-127,781.00
-88,993.00
-115,982.00
Investing Cash Flow
-1,208.00
-1,115.00
-1,255.00
-560.00
-1,338.00
Financing Cash Flow
312,871.00
132,534.00
67,188.00
55,828.00
154,538.00
End Cash Position
314,671.00
204,050.00
92,157.00
154,215.00
188,148.00
Capital Expenditure
-1,208.00
-1,115.00
-1,361.00
-560.00
-1,338.00
Issuance of Capital Stock
296,805.00
131,277.00
52,325.00
54,970.00
153,626.00
Free Cash Flow
-141,825.00
-20,546.00
-129,142.00
-89,553.00
-117,320.00
12/31/2020 - 4/23/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
9IP1.F Rocket Pharmaceuticals, Inc.
9.94
+3.37%
0K4.BE Akero Therapeutics Inc
54.28
+1.00%
BBZA.F BB Biotech AG Ord
42.70
+0.23%
0K4.F Akero Therapeutics, Inc.
54.08
+4.77%
COYA Coya Therapeutics, Inc.
5.86
+0.17%
22UA.DE BioNTech SE
118.40
-0.17%
MTEM Molecular Templates, Inc.
0.0003
+200.00%
EDSA Edesa Biotech, Inc.
1.8900
+1.07%
ANIX Anixa Biosciences, Inc.
2.9400
-2.00%
MGNX MacroGenics, Inc.
3.0100
-0.66%